Kiran Gajurel

Significance of a Positive Toxoplasma Immunoglobulin M Test Result in the United States

Reshika Dhakal, Kiran Gajurel, Christelle Pomarès et al. · Journal of Clinical Microbiology · 2015 · 94 citations · Full text

Molecular Diagnostic Techniques, Autoimmune Disease, Medicine +12

Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

Zelalem Temesgen, Charles D. Burger, Jason Baker et al. · The Lancet Respiratory Medicine · 2021 · 70 citations · Full text

Covid-19 Pandemic, Respiratory Infection, Infectious Respiratory Disease +6

Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: a Randomized, Placebo-Controlled First-in-Human Single-Dose Escalation Study

Guohua An, Daryl J. Murry, Kiran Gajurel et al. · Antimicrobial Agents and Chemotherapy · 2019 · 42 citations · Full text

Molecular and Culture-Based Bronchoalveolar Lavage Fluid Testing for the Diagnosis of Cytomegalovirus Pneumonitis

Susanna K. Tan, Elizabeth B. Burgener, Jesse J. Waggoner et al. · Open Forum Infectious Diseases · 2015 · 39 citations · Full text

Cmv Diagnostic Methods, Diagnostic Virology, Cytomegalovirus Pneumonitis +10

Failure of primary atovaquone prophylaxis for prevention of toxoplasmosis in hematopoietic cell transplant recipients

Kiran Gajurel, Carlos A. Gómez, Reshika Dhakal et al. · Transplant Infectious Disease · 2016 · 28 citations

Atovaquone Prophylaxis, Transplantation, Marrow Transplantation +11